Catalyst Pharmaceuticals (CPRX)
(Delayed Data from NSDQ)
$15.12 USD
+0.39 (2.65%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $15.12 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
B Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC5/8/24 |
---|---|
Current Quarter | 0.34 |
EPS Last Quarter | 0.53 |
Last EPS Surprise | 10.42% |
ABR | 1.00 |
Earnings ESP
|
-10.71% |
---|---|
Current Year | 1.91 |
Next Year | 2.32 |
EPS (TTM) | 0.88 |
P/E (F1) | 7.73 |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 97.59M | 111.36M | 460.60M | 540.94M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 107.32M | 112.75M | 465.60M | 579.80M |
Low Estimate | 91.40M | 109.58M | 457.65M | 521.91M |
Year ago Sales | 85.37M | 99.58M | 398.20M | 460.60M |
Year over Year Growth Est. | 14.32% | 11.83% | 15.67% | 17.44% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.34 | 0.47 | 1.91 | 2.32 |
# of Estimates | 5 | 4 | 5 | 5 |
Most Recent Consensus | 0.45 | 0.57 | 2.31 | 2.70 |
High Estimate | 0.45 | 0.57 | 2.31 | 2.70 |
Low Estimate | 0.26 | 0.39 | 1.66 | 1.98 |
Year ago EPS | 0.26 | 0.33 | 1.96 | 1.91 |
Year over Year Growth Est. | 30.77% | 42.42% | -2.55% | 21.68% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 0 | 0 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 4 | 3 | 4 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.34 | 0.47 | 1.91 | 2.32 |
7 Days Ago | 0.34 | 0.47 | 1.91 | 2.32 |
30 Days Ago | 0.36 | 0.45 | 1.88 | 2.31 |
60 Days Ago | 0.52 | 0.58 | 2.38 | 2.78 |
90 Days Ago | 0.52 | 0.58 | 2.41 | 2.81 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.30 | 0.39 | 1.76 | 2.21 |
Zacks Consensus Estimate | 0.34 | 0.47 | 1.91 | 2.32 |
Earnings ESP | -10.71% | -16.13% | -7.66% | -4.96% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.53 | -0.24 | 0.33 | 0.26 | NA |
Estimate | 0.48 | -0.24 | 0.25 | 0.30 | NA |
Difference | 0.05 | 0.00 | 0.08 | -0.04 | 0.02 |
Surprise | 10.42% | 0.00% | 32.00% | -13.33% | 7.27% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more